Last update 20 Aug 2026

ABBV-722

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ABBV-722
Target
LPAR1
Action
antagonists
Mechanism
LPAR1 antagonists(Lysophosphatidic acid receptor Edg-2 antagonists)
Therapeutic Areas
Immune System DiseasesRespiratory DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication
Rheumatoid ArthritisIdiopathic Pulmonary FibrosisScleroderma, Systemic
Inactive Indication-
Originator Organization
AbbVie, Inc.AbbVie, Inc.
Active Organization
AbbVie, Inc.AbbVie, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

6
Clinical Trials associated with ABBV-722
NCT07599761
/ RecruitingPhase 1
A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics, Safety, and Tolerability of ABBV-722 in Healthy Adult Subjects
NCT07567781
/ Active, not recruitingPhase 1
A Phase 1 Study to Evaluate the Effect of Multiple Doses of ABBV-722 on the Pharmacokinetics of Cocktail Probe Substrates of CYP3A and Select Transporters in Healthy Adult Subjects
NCT07502417
/ CompletedPhase 1
A Phase 1 Study to Assess the Effect of Multiple Doses of ABBV-722 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel
100 Clinical Results associated with ABBV-722
Login to view more data
100 Translational Medicine associated with ABBV-722
Login to view more data
100 Patents (Medical) associated with ABBV-722
Login to view more data
100 Deals associated with ABBV-722
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rheumatoid ArthritisPhase 1
United States
AbbVie, Inc.AbbVie, Inc.
26 Feb 2026
Idiopathic Pulmonary FibrosisPhase 1
United States
AbbVie, Inc.AbbVie, Inc.
09 Oct 2024
Scleroderma, SystemicPhase 1
United States
AbbVie, Inc.AbbVie, Inc.
09 Oct 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free